Department of Nutritional Science, Fu Jen Catholic University, New Taipei City, Taiwan.
Division of Applied Bioresource Chemistry, the United Graduate School of Agricultural Sciences, Tottori University, Tottori, Japan.
Eur J Nutr. 2024 Dec;63(8):3269-3279. doi: 10.1007/s00394-024-03505-9. Epub 2024 Oct 1.
To investigate the bioavailability of vitamin B from nori and to evaluate the required dosage for improving vitamin B nutritional status in vegetarians not using supplements.
The study design is an open-label, parallel, dose-response randomized controlled trial. Thirty vegetarians were assigned to control (no nori), low-dose (5 g nori, aiming to provide 2.4 µg vitamin B per day), or high-dose (8 g nori, aiming to provide 4 µg vitamin B per day) groups. The primary outcome was changes in vitamin B status as measured by serum vitamin B, holotranscobalamin (holoTC), homocysteine (Hcy), and methylmalonic acid (MMA), and a combined score of these four markers (4cB12 score) during the four-week intervention. Dietary vitamin B intakes were assessed at baseline and end of the trial with a 17-item food frequency questionnaire designed for vitamin B assessment. General linear model was used to compare least square means of changes in each biomarker of vitamin B status, among the three groups, while adjusting for respective baseline biomarker.
After adjusting for baseline status, nori consumption led to significant improvement in serum vitamin B (among-group P-value = 0.0029), holoTC (P = 0.0127), Hcy (P = 0.0225), and 4cB12 (P = 0.0094). Changes in MMA did not differ significantly across groups, but showed within-group pre-post improvement in the low-dose group (median [p25, p75] = -339 [-461, -198] nmol/L). Vitamin B status appeared to plateau at low dose (5 g of nori), which compared with control group, improved serum vitamin B (lease square mean [95% CI] = + 59 [25, 93] pmol/L, P = 0.0014); holoTC (+ 28.2 [10.1, 46.3] pmol/L, P = 0.0035); Hcy (-3.7 [-6.8, -0.6] µmol/L, p = 0.0226); and 4cB12 score (+ 0.67 [0.24, 1.09], p = 0.0036). High-dose resulted in similar improvements. There was no significant difference between low-dose and high-dose groups in all biomarkers of vitamin B.
Consuming 5 g of nori per day for 4 weeks significantly improved vitamin B status in vegetarians. A higher dose (8 g) may not confer additional benefits.
ClinicalTrials.gov Identifier: NCT05614960. Date of registration: November 14th 2022.
研究紫菜中维生素 B 的生物利用度,并评估素食者在不使用补充剂的情况下改善维生素 B 营养状况所需的剂量。
研究设计为开放标签、平行、剂量反应随机对照试验。将 30 名素食者分为对照组(不食用紫菜)、低剂量组(5g 紫菜,旨在提供每天 2.4μg 维生素 B)和高剂量组(8g 紫菜,旨在提供每天 4μg 维生素 B)。主要结局是血清维生素 B、全钴胺素(holoTC)、同型半胱氨酸(Hcy)和甲基丙二酸(MMA)的维生素 B 状态变化,以及这四个标志物的综合评分(4cB12 评分)在四周干预期间的变化。采用专门设计用于评估维生素 B 的 17 项食物频率问卷,在基线和试验结束时评估膳食维生素 B 摄入量。采用一般线性模型比较三组间各维生素 B 状态生物标志物的最小二乘均值变化,同时调整各自的基线生物标志物。
在调整基线状态后,紫菜的摄入导致血清维生素 B(组间 P 值=0.0029)、holoTC(P=0.0127)、Hcy(P=0.0225)和 4cB12(P=0.0094)显著改善。MMA 的变化在组间无显著差异,但低剂量组在组内出现了前后改善(中位数[p25,p75]=-339[-461,-198]nmol/L)。维生素 B 状态在低剂量(5g 紫菜)时似乎达到了平台期,与对照组相比,血清维生素 B 得到改善(最小二乘均值[95%CI]
=+59[25,93]pmol/L,P=0.0014);holoTC(+28.2[10.1,46.3]pmol/L,P=0.0035);Hcy(-3.7[-6.8,-0.6]µmol/L,P=0.0226);和 4cB12 评分(+0.67[0.24,1.09],P=0.0036)。高剂量也有类似的改善。在所有维生素 B 生物标志物中,低剂量组和高剂量组之间均无显著差异。
素食者每天食用 5g 紫菜连续 4 周可显著改善维生素 B 状态。更高的剂量(8g)可能不会带来额外的益处。
ClinicalTrials.gov 标识符:NCT05614960。注册日期:2022 年 11 月 14 日。